Helsinki - Delayed Quote EUR

Remedy Entertainment Oyj (REMEDY.HE)

18.70
+0.74
+(4.12%)
At close: May 14 at 6:29:46 PM GMT+3
Loading Chart for REMEDY.HE
  • Previous Close 17.96
  • Open 17.96
  • Bid 18.70 x --
  • Ask 18.80 x --
  • Day's Range 17.94 - 18.90
  • 52 Week Range 12.10 - 22.35
  • Volume 16,087
  • Avg. Volume 7,886
  • Market Cap (intraday) 254.081M
  • Beta (5Y Monthly) 0.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.08
  • Earnings Date Aug 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Apr 14, 2023
  • 1y Target Est 19.50

Remedy Entertainment Oyj, a video game company, engages in the development and sale of PC and console games in Finland. It primarily creates story-driven and action games. The company also provides franchises under the Control, Alan Wake, and Max Payne brand names. Remedy Entertainment Oyj was incorporated in 1995 and is headquartered in Espoo, Finland.

www.remedygames.com

373

Full Time Employees

December 31

Fiscal Year Ends

Recent News: REMEDY.HE

View More

Performance Overview: REMEDY.HE

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is OMX Helsinki_PI (^OMXHPI) .

YTD Return

REMEDY.HE
33.00%
OMX Helsinki_PI (^OMXHPI)
0.00%

1-Year Return

REMEDY.HE
2.71%
OMX Helsinki_PI (^OMXHPI)
0.00%

3-Year Return

REMEDY.HE
35.90%
OMX Helsinki_PI (^OMXHPI)
0.00%

5-Year Return

REMEDY.HE
9.83%
OMX Helsinki_PI (^OMXHPI)
0.00%

Compare To: REMEDY.HE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: REMEDY.HE

View More

Valuation Measures

As of 5/13/2025
  • Market Cap

    244.03M

  • Enterprise Value

    231.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.59

  • Price/Book (mrq)

    3.50

  • Enterprise Value/Revenue

    4.35

  • Enterprise Value/EBITDA

    32.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.90%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    -1.48%

  • Revenue (ttm)

    53.26M

  • Net Income Avi to Common (ttm)

    -1.01M

  • Diluted EPS (ttm)

    -0.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    27.97M

  • Total Debt/Equity (mrq)

    22.51%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: REMEDY.HE

View More

People Also Watch